, Concernant les facteurs associés aux tremblements induits par le Lithium, une tendance est observée pour: les benzodiazépines principalement (p=0,056)

, Diagnostic and statistical manual of mental disorders: DSM-5. 5 ème ed

. Washington, American Psychiatric Association, 2013.

H. Autorité-de-santé,

J. Scott and M. Leboyer, Consequences of delayed diagnosis of bipolar disorders, L'Encéphale. déc, vol.37, pp.5173-5175, 2011.

L. N. Yatham, S. H. Kennedy, S. V. Parikh, A. Schaffer, D. J. Bond et al., Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder, Bipolar Disord. mars, vol.20, issue.2, pp.97-170, 2018.

R. Belzeaux, N. Correard, and L. Boyer, Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: Results from the FACE-BD cohort, J Affect Disord. déc, vol.151, issue.3, pp.1009-1015, 2013.

J. C. Morgan and K. D. Sethi, Drug-induced tremors, Lancet Neurol. 1 déc, vol.4, issue.12, pp.866-876, 2005.

M. Dias-alves, L. Varin, and L. M. Fiori, Efficacy of Vitamin B6 in Lithium-Associated Tremor: A Case Series, J Clin Psychopharmacol. avr, vol.37, issue.2, pp.267-269, 2017.

M. L. Bourgeois and C. Gay, Les Troubles Bipolaires, 2014.

F. K. Goodwin and K. R. Jamison, Manic-depressive illness, 1990.

E. Kraepelin, Cent ans de psychiatrie, suivi de : la folie maniaco dépressive 1899, 1997.

J. Angst and M. Preisig, Course of a clinical cohort of unipolar, bipolar and schizoaffective patients, Schweiz Arch Neurol Psychiatr, vol.146, issue.1, pp.5-16, 1985.

C. Perris, A study of bipolar ans unipolar recurrent depressive psyhosis, Acta Psychiatrica Scandinavica, 1966.

G. Winokur, W. Coryelle, and J. Endicott, Further distinctions between manicdepressive illness (bipolar disorder) and primary depressive disorder (unipolar depression)

, Am J Psychiatry, 1993.

R. C. Kessler, Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States: Results From the National Comorbidity Survey, Arch Gen Psychiatry. 1 janv, vol.51, issue.1, p.8, 1994.

D. A. Regier and C. T. Kaelber, The epidemiologic catchment area (ECA) program studying the prevalence and incidence of psychopathology, 1995.

F. Rouillon, Épidémiologie du trouble bipolaire, Ann Méd-Psychol Rev Psychiatr. déc, vol.167, issue.10, pp.793-795, 2009.

F. Mémo, Patient avec un trouble bipolaire : repérage et prise en charge initiale en premier recours. Ann Méd-Psychol Rev Psychiatr, vol.174, pp.862-870, 2016.

C. Gay and . L'encéphale, J Homepage www.elseviercom locateencep, 2008.

J. Angst, F. Angst, and R. Gerber-werder, Suicide in 406 Mood-Disorder Patients With and Without Long-Term Medication: A 40 to 44 Years' Follow-Up, Arch Suicide Res. juill, vol.9, issue.3, pp.279-300, 2005.

C. Murray and A. D. Lopez, Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study, vol.274, pp.740-743, 1996.

P. A. Geoffroy, B. Etain, and J. Scott, Reconsideration of bipolar disorder as a developmental disorder: Importance of the time of onset, J Physiol-Paris. sept, vol.107, issue.4, pp.278-285, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00811691

J. R. Geddes and D. J. Miklowitz, Treatment of bipolar disorder, The Lancet. mai, vol.381, issue.9878, pp.1672-1682, 2013.

, Practice guideline for the treatment of patients with bipolar disorder (revision)

, American Psychiatric Association, 2002.

A. Pfennig, T. Bschor, and P. Falkai, The Diagnosis and Treatment of Bipolar Disorder, Dtsch Aerzteblatt Online. 2 août, 2013.

G. S. Malhi, D. Bassett, and P. Boyce, Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders, Aust N Z J Psychiatry. déc, vol.49, issue.12, pp.1087-1206, 2015.

E. Severus, M. J. Taylor, and C. Sauer, 20 déc 2014;2. 27. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. The Lancet, Int J Bipolar Disord, vol.375, issue.9712, pp.385-95, 2010.

A. Cipriani, H. Pretty, and K. Hawton, Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials, Am J Psychiatry, vol.162, issue.10, pp.1805-1819, 2005.

L. Samalin, S. Guillaume, and P. Courtet, Recommandations Formalisées d'Experts de l'Association Française de Psychiatrie Biologique et Neuropsychopharmacologie sur le dépistage et prise en charge du trouble bipolaire : mise à jour, L'Encéphale. Fev, vol.41, issue.1, pp.93-102, 2014.

T. L. Ngô, M. D. Provencher, and J. Goulet, Guide de pratique pour le diagnostic et le traitement du trouble bipolaire, Disponible sur: . Disponibilité sur Internet, 2015.

F. Colom, E. Vieta, and J. Sánchez-moreno, Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial, Br J Psychiatry. mars, vol.194, issue.3, pp.260-265, 2009.

S. Miziou, E. Tsitsipa, and S. Moysidou, Psychosocial treatment and interventions for bipolar disorder: a systematic review, Ann Gen Psychiatry. déc, vol.14, issue.1, p.19, 2015.

E. Shorter, The history of lithium therapy, Bipolar Disord. juin, vol.11, issue.2, pp.4-9, 2009.

R. W. Licht, Lithium: Still a Major Option in the Management of Bipolar Disorder, CNS Neurosci Ther. mars, vol.18, issue.3, pp.219-226, 2012.

C. Blanco, G. Laje, and M. Olfson, Trends in the treatment of bipolar disorder by outpatient psychiatrists, Am J Psychiatry. juin, vol.159, issue.6, pp.1005-1010, 2002.

J. Moncrieff, Lithium: evidence reconsidered, Br J Psychiatry. août, vol.171, pp.113-119, 1997.

A. H. Young and J. M. Hammond, Lithium in mood disorders: increasing evidence base, declining use?, Br J Psychiatry. déc, vol.191, pp.474-480, 2007.

D. Deshauer, D. Fergusson, and A. Duffy, Re-evaluation of randomized control trials of lithium monotherapy: a cohort effect, Bipolar Disord. août, vol.7, issue.4, pp.382-387, 2205.

J. W. Jefferson, Old versus new medications: how much should be taught? Acad Psychiatry, juin, vol.29, issue.2, pp.162-166, 2005.

G. Curran and A. Ravindran, Lithium for bipolar disorder: a review of the recent literature, Expert Rev Neurother. sept, vol.14, issue.9, pp.1079-98, 2014.

N. Kleindienst and W. Greil, Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study, Neuropsychobiology, vol.42, issue.1, pp.2-10, 2000.

R. J. Baldessarini, L. Tondo, and J. Hennen, Lithium treatment and suicide risk in major affective disorders: update and new findings, J Clin Psychiatry, vol.64, issue.5, pp.44-52, 2003.

P. Grof, Responders to long-term lithium treatment, Lithium Neuropsychiatry. 23 mai, 2013.

G. S. Malhi, M. Tanious, and P. Das, The science and practice of lithium therapy, Aust N Z J Psychiatry. 1 mars, vol.46, issue.3, pp.192-211, 2012.

E. Won and Y. K. Kim, An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms, Int J Mol Sci. 11 déc, vol.18, issue.12, 2017.

. Vidal--teralithe, LP 400 mg cp séc LP -Synthèse

F. Ng, O. K. Mammen, and I. Wilting, The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments, British Psychological Society, vol.11, issue.6, pp.559-595, 2006.

W. E. Severus, N. Kleindienst, and G. Evoniuk, Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study, J Affect Disord. juin, vol.115, issue.3, pp.466-470, 2009.

M. Gitlin, Lithium side effects and toxicity: prevalence and management strategies, Int J Bipolar Disord. déc, vol.4, issue.1, p.27, 2016.

D. Sur,

R. F. Mcknight, M. Adida, and K. Budge, Lithium toxicity profile: a systematic review and meta-analysis. . The Lancet, Fev, vol.379, issue.9817, pp.721-728, 2012.

A. Koukopoulos, D. Reginaldi, and L. Tondo, Course sequences in bipolar disorder: Depressions preceding or following manias or hypomanias, J Affect Disord, vol.151, issue.1, pp.105-110, 2013.

G. S. Malhi, D. Gessler, and T. Outhred, The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines, J Affect Disord. 1 août, vol.217, pp.266-280, 2017.

L. Tondo, A. M. Bauer, and M. , Clinical use of lithium salts: guide for users and prescribers, Int J Bipolar Disord. 22 juill, vol.7, 2019.

R. M. Post, Acquired lithium resistance revisited: discontinuation-induced refractoriness versus tolerance, J Affect Disord. sept, vol.140, issue.1, pp.6-13, 2012.

M. Fornaro, B. Stubbs, D. Berardis, and D. , Does the « Silver Bullet » Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients, Clin Pr Epidemiol Ment Health, vol.12, pp.142-157, 2016.

L. Tondo, R. J. Baldessarini, and J. Hennen, Lithium and Suicide Risk in Bipolar Disorder, CNS Spectr, vol.5, issue.S1, pp.6-11, 2000.

R. J. Baldessarini and L. Tondo, Effects of Treatment Discontinuation in Clinical Psychopharmacology, Psychother Psychosom, vol.88, issue.2, pp.65-70, 2019.

L. Öhlund, M. Ott, and S. Oja, Reasons for lithium discontinuation in men and women with bipolar disorder: a retrospective cohort study, BMC Psychiatry. déc, vol.18, issue.1, p.37, 2018.

G. Deuschl, P. Bain, and M. Brin, Consensus Statement of the Movement Disorder Society on Tremor. Mov Disord, vol.13, issue.S3, pp.2-23, 1998.

D. B. Calne and H. L. Klawans, Pathophysiology and pharmacotherapy of tremor, Pharmacol Ther Part C Clin Pharmacol Ther. 1 janv, vol.2, issue.1, pp.113-123, 1977.

J. H. Baek, G. Kinrys, and A. A. Nierenberg, Lithium tremor revisited: pathophysiology and treatment, Acta Psychiatr Scand, vol.129, issue.1, pp.17-23

J. Neiman, A. E. Lang, and L. Fornazzari, Movement disorders in alcoholism: A review, Neurology. 1 mai, vol.40, issue.5, pp.741-741, 1990.

C. Y. Lin, C. H. Yeh, and T. T. Chang, Dopamine Transporter, and Hand Tremor, Clin Nucl Med. janv, vol.37, issue.1, p.35, 2012.

E. D. Louis, Kinetic tremor: Differences between smokers and non-smokers, NeuroToxicology. 1 mai, vol.28, issue.3, pp.569-575, 2007.

W. Koller, S. Cone, and G. Herbster, Caffeine and tremor, Neurology. 1 janv, vol.37, issue.1, pp.169-169, 1987.

, Lithium tremor and caffeine intake: two cases of drinking less and shaking more

G. Mostile and J. Jankovic, Alcohol in essential tremor and other movement disorders, Mov Disord, vol.25, issue.14, pp.2274-2284, 2010.

L. Strat and Y. , Trouble bipolaire et comorbidités addictives. Ann Méd-Psychol Rev Psychiatr, vol.168, pp.584-587, 2010.

, Peripheral Mechanical Loading and the Mechanism of the Tremor of Chronic Alcoholism, JAMA Neurology | JAMA Network

A. Anouti and W. C. Koller, Tremor disorders. Diagnosis and management, Tremor in chronic alcoholism | Neurology, vol.162, pp.510-513, 1995.

D. H. Zilm, Propranolol Effect on Tremor in Alcoholic Withdrawal, Ann Intern Med. 8 janv, vol.83, issue.2, p.234, 1975.

, Changes in the Sensitivity of Dopamine Receptors in the Nucleus Accumbens and in the Striatum Induced by Chronic Ethanol Administration -Liljequist -1978 -Acta Pharmacologica et Toxicologica -Wiley Online Library

O. Sergent, B. Griffon, and P. Cillard, Alcool et stress oxydatif, Pathol Biol. 1 janv, vol.49, issue.9, pp.689-695, 2001.

, Lithium treatment during alcoholic withdrawal -Sellers -1976 -Clinical Pharmacology &amp

M. Daras and B. S. Koppel, Atos-Radzion E. Cocaine-induced choreoathetoid movements ('crack dancing'), Neurology. 1 avr, vol.44, issue.4, pp.751-751, 1994.

L. A. Downey, . La, B. Tysse, T. C. Ford, and . Tc, Psychomotor Tremor and Proprioceptive Control Problems in Current and Former Stimulant Drug Users: An Accelerometer Study of Heavy Users of Amphetamine, MDMA, and Other Recreational Stimulants, J Clin Psychopharmacol, vol.57, issue.10, pp.1330-1337, 2017.

L. O. Bauer, Resting Hand Tremor in Abstinent Cocaine-Dependent, Alcohol-Dependent, and Polydrug-Dependent Patients, Alcohol Clin Exp Res, vol.20, issue.7, pp.1196-1201, 1996.

F. Cardoso and J. Jankovic, Cocaine-related movement disorders, Mov Disord, vol.8, issue.2, pp.175-178, 1993.

, Side Effects of Methylphenidate and Desipramine Alone and in Combination in Children -ScienceDirect

, Finger tremor and cigarette smoking. -Lippold -1980 -British Journal of Clinical Pharmacology -Wiley Online Library. 85. Effects of cigarette smoking and oral nicotine on hand tremor -Shiffman -1983 -Clinical Pharmacology &amp

K. R. Müller-vahl, H. Kolbe, U. Schneider, and H. M. Emrich, Cannabis in Movement Disorders, Complement Med Res, vol.6, issue.3, pp.23-27, 1999.

J. P. Frankel, A. Hughes, A. J. Lees, and G. M. Stern, Marijuana for parkinsonian tremor, J Neurol Neurosurg Psychiatry. 1 mai, vol.53, issue.5, pp.436-436, 1990.

P. Fox, P. G. Bain, and S. Glickman, The effect of cannabis on tremor in patients with multiple sclerosis, Neurology. 13 avr, vol.62, issue.7, pp.1105-1109, 2004.

M. J. Shirlow and C. D. Mathers, A Study of Caffeine Consumption and Symptoms: Indigestion, Palpitations, Tremor, Headache and Insomnia, Int J Epidemiol. 1 juin, vol.14, issue.2, pp.239-248, 1985.

, Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome. -Abstract -Europe PMC. 91. Rapidly progressive parkinsonism in a self-reported user of Ecstasy and other drugs -O'Suilleabhain -2003 -Movement Disorders

S. M. Kuniyoshi, J. Jankovic, and P. Mdma, , 2009.

A. J. Gelenberg and J. W. Jefferson, Lithium tremor, J Clin Psychiatry. juill, vol.56, issue.7, pp.283-287, 1995.

D. L. Dunner, Optimizing lithium treatment, J Clin Psychiatry, vol.61, issue.9, pp.76-81, 2000.

M. Bauer and M. Gitlin, Adverse Effects of Lithium and Their Management, 2002.

J. Marshall, Observations on essential tremor, J Neurol Neurosurg Psychiatry. mai, vol.25, issue.2, pp.122-125, 1962.

P. Tyrer, L. Lee, and C. Trotter, Physiological Characteristics of Tremor after Chronic Lithium Therapy, Br J Psychiatry. juill, vol.139, issue.1, pp.59-61, 1981.

M. Gitlin, Lithium side effects and toxicity: prevalence and management strategies, Int J Bipolar Disord. déc, vol.4, issue.1, p.27, 2016.

F. Novellino, A. Cherubini, and C. Chiriaco, Brain iron deposition in essential tremor: A quantitative 3-tesla magnetic resonance imaging study: Iron Deposition in ET, Mov Disord. Fev, vol.28, issue.2, pp.196-200, 2013.

, Lithium Associated Side Effects and Neurotoxicity: Is Lithium Neurotoxicity Related to Iron Deposition? -ProQuest

J. C. Desport and P. Couratier, Stress oxydant et maladies neurodégénératives, Nutr Clin Métabolisme. déc, vol.16, issue.4, pp.253-259, 2002.

P. R. Faustino, G. S. Duarte, and I. Chendo, Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis, JAMA Neurol. 1 févr, vol.77, issue.2, pp.192-198, 2020.

, Clinical Measurement of Tremor -Bain -1998 -Movement Disorders

P. Vestergaard, I. Poulstrup, and M. Schou, Prospective studies on a lithium cohort, Acta Psychiatr Scand, vol.78, issue.4, pp.434-441, 1988.

G. Deuschl, J. Raethjen, and H. Hellriegel, Treatment of patients with essential tremor, Lancet Neurol. févr, vol.10, issue.2, pp.148-161, 2011.

L. Kirk, P. C. Baastrup, and M. Schou, Propranolol treatment of lithium induced tremor, The Lancet, vol.302, pp.1086-1087, 1973.

G. S. Zubenko, B. M. Cohen, and J. F. Lipinski, Comparison of metoprolol and propranolol in the treatment of lithium tremor, Psychiatry Res. févr, vol.11, issue.2, pp.163-164, 1984.

M. Schou and P. Vestergaard, Use of propranolol during lithium treatment: An enquiry and a suggestion, Pharmacopsychiatry, 1987.

, Beta blockade in lithium tremor, Neurosurgery & Psychiatry

D. Sur,

N. S. Gaby, D. S. Lefkowitz, and J. R. Israel, Treatment of lithium tremor with metoprolol, Am J Psychiatry. mai, vol.140, issue.5, pp.593-595, 1983.

J. M. Kruse, L. Ereshefsky, and M. Scavone, Treatment of lithium-induced tremor with nadolol, Clin Pharm. juin, vol.3, issue.3, pp.299-301, 1984.

M. Davé, Treatment of lithium induced tremor with atenolol, Can J Psychiatry. mars, vol.34, issue.2, pp.132-133, 1989.

A. D. Goumentouk, T. A. Hurwitz, and A. P. Zis, Primidone in drug-induced tremor, J Clin Psychopharmacol. déc, vol.9, issue.6, p.451, 1989.

D. M. Marks, C. U. Pae, and A. A. Patkar, Potential role of pregabalin in the treatment of lithium-induced tremor: a case report, Int J Neuropsychopharmacol. sept, vol.11, issue.6, pp.879-881, 2008.

G. S. Connor, K. Edwards, and D. Tarsy, Topiramate in Essential Tremor: Findings from Double-Blind, Placebo-Controlled, Crossover Trials, Clin Neuropharmacol. avr, vol.31, issue.2, p.97, 2008.

J. Lieb, Linoleic acid in the treatment of lithium toxicity and familial tremor, Prostaglandins Med. avr, vol.4, issue.4, pp.275-279, 1980.

M. Schou, Linoleic acid in the treatment of lithium-induced tremor: a pilot trial with negative outcome, Prostaglandins Med. nov, vol.5, issue.5, pp.343-344, 1980.

C. Miodownik, E. Witztum, and V. Lerner, Lithium-Induced Tremor Treated with Vitamin B 6 : A Preliminary Case Series, Int J Psychiatry. mars, vol.32, issue.1, pp.103-108, 2002.

, Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia -Adelufosi

I. H. Rosenberg, A History of the Isolation and Identification of Vitamin B6

A. , , vol.61, pp.236-238, 2012.

H. Hellmann and S. Mooney, Vitamin B6: A Molecule for Human Health?, Molecules. janv, vol.15, issue.1, pp.442-459, 2010.

R. Contestabile, Biomedical aspects of pyridoxal 5 -phosphate availability, Front Biosci, vol.4, issue.3, pp.897-913, 2012.

P. Bilski, M. Y. Li, and M. Ehrenshaft, Vitamin B6 (Pyridoxine) and Its Derivatives Are Efficient Singlet Oxygen Quenchers and Potential Fungal Antioxidants, Photochem Photobiol, vol.71, issue.2, pp.129-134, 2000.

H. Vanderschuren, S. Boycheva, and K. T. Li, Strategies for vitamin B6 biofortification of plants: a dual role as a micronutrient and a stress protectant, Front Plant Sci, vol.4, 2013.

A. H. Merrill and J. M. Henderson, Diseases Associated with Defects in Vitamin B6 Metabolism or Utilization, Annu Rev Nutr, vol.7, issue.1, pp.137-156, 1987.

T. R. Guilarte, Effect of vitamin B-6 nutrition on the levels of dopamine, dopamine metabolites, dopa decarboxylase activity, tyrosine, and GABA in the developing rat corpus striatum, Neurochem Res. juin, vol.14, issue.6, pp.571-578, 1989.

C. Miodownik, A. Meoded, and I. Libov, Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesia, Clin Neuropharmacol. août, vol.31, issue.4, pp.197-203, 2008.

D. Bonke and B. Nickel, Improvement of fine motoric movement control by elevated dosages of vitamin B1, B6, and B12 in target shooting, Int J Vitam Nutr Res Suppl, vol.30, pp.198-204, 1989.

V. Lerner, C. Miodownik, and A. Kaptsan, Vitamin B6 in the Treatment of Tardive Dyskinesia: A Double-Blind, Placebo-Controlled, Crossover Study, Am J Psychiatry. 1 sept, vol.158, issue.9, pp.1511-1514, 2001.

V. Lerner, C. Miodownik, and A. Kaptsan, Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study, J Clin Psychiatry, vol.68, issue.11, pp.1648-1654, 2011.

C. Miodownik, H. Cohen, and M. Kotler, Vitamin B6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders

, Harefuah. sept, vol.142, issue.8-9, pp.592-647, 2003.

X. Y. Zhang, D. F. Zhou, and L. Y. Cao, The Effect of Vitamin E Treatment on Tardive Dyskinesia and Blood Superoxide Dismutase: A Double-Blind Placebo-Controlled Trial, J Clin Psychopharmacol. févr, vol.24, issue.1, p.83, 2004.

. Vitamine and . Parkinson,

M. G. Cohen and A. Bendich, Safety of pyridoxine-a review of human and animal studies, Toxicol Lett, vol.34, issue.2-3, pp.129-139, 1986.

, Sensory Neuropathy from Pyridoxine Abuse -A New Megavitamin Syndrome | NEJM

, Pyridoxine-induced sensory ataxic neuronopathy and neuropathy: revisited | SpringerLink

. Vidal--becilan, 250 mg cp séc -Interactions

G. Chouinard and H. C. Margolese, Manual for the Extrapyramidal Symptom Rating Scale (ESRS), Schizophr Res. 5 juill, vol.76, issue.2, pp.247-265, 2005.

S. Pullinger and P. Tyrer, Acute Lithium-Induced Tremor, Br J Psychiatry, vol.143, issue.1, pp.40-41, 1983.

P. Tyrer, M. S. Alexander, and A. Regan, An Extrapyramidal Syndrome after Lithium Therapy, Br J Psychiatry, vol.136, issue.2, pp.191-194, 1980.

P. Lei, S. Ayton, and A. T. Appukuttan, Lithium suppression of tau induces brain iron accumulation and neurodegeneration, Mol Psychiatry. mars, vol.22, issue.3, pp.396-406, 2017.

X. Leverve, Stress oxydant et antioxydants ? Cah Nutr Diététique, vol.44, pp.219-224, 2009.

, VIDAL -ABILIFY 10 mg cp -Synthèse

D. Sur,

A. Lui, L. Lumeng, and T. K. Li, Metabolism of vitamin B6 in rat liver mitochondria, J Biol Chem. 25 juin, vol.256, issue.12, pp.6041-6046, 1981.

. Netgen, Le polymorphisme génétique du cytochrome P450 2D6 : le Bon, l'Ultrarapide, l'Intermédiaire et le Lent

M. Edeas, D. Attaf, and A. S. Mailfert, Maillard Reaction, mitochondria and oxidative stress: Potential role of antioxidants, Pathol Biol. 20 juin, vol.58, issue.3, pp.220-225, 2010.

J. C. Martinou, Dynamique mitochondriale : de la géométrie à la fonction des mitochondries, Med Sci Paris, vol.26, issue.10, pp.783-786, 2010.

C. A. Gautier, O. Corti, and A. Brice, Mitochondrial dysfunctions in Parkinson's disease, Rev Neurol (Paris). 1 mai, vol.170, issue.5, pp.339-343, 2014.

M. O. Krebs, Génétique des troubles bipolaires et environnement, L'Encéphale. juin, vol.34, pp.123-126, 2008.

K. Kannan and S. K. Jain, Effect of vitamin B6 on oxygen radicals, mitochondrial membrane potential, and lipid peroxidation in H2O2-treated U937 monocytes, Free Radic Biol Med. 15 févr, vol.36, issue.4, pp.423-428, 2004.